Abstract
Glioma is the most common primary malignant brain tumor, which faces great challenges in clinical treatment due to its high invasiveness and resistance to existing treatments. In recent years, the zebrafish model has gradually become an important tool for glioma research due to its advantages such as easy genetic manipulation, strong optical transparency, and suitability for high-throughput imaging and drug screening. This article systematically reviews the three main strategies for zebrafish glioma modeling—chemical mutagenesis, genetic engineering, and xenotransplantation—and describes their research applications in tumorigenesis, invasion process, and treatment response. At the same time, this article deeply analyzes the limitations of the zebrafish model in terms of temperature differences, delayed development of the blood-brain barrier, and immature immune system, and introduces the cutting-edge progress in recent years in the fields of CRISPR-mediated immune regulation, construction of high-temperature resistant strains, and development of humanized models. Through a comprehensive review of current research applications, key challenges, and future development directions, this article emphasizes the potential value of the zebrafish model as an important supplement to the mammalian model in exploring the immune mechanism of glioma and developing innovative treatment strategies.
Introduction: The Challenge of Glioma
Glioblastoma Multiforme (GBM) is notoriously difficult to treat, characterized by its aggressive invasion into surrounding brain tissue and the protective shield of the blood-brain barrier (BBB). While murine models have long been the standard for oncological research, they present significant hurdles: they are expensive, time-consuming, and difficult to image at a single-cell resolution within a living host.
Researchers are increasingly turning to the zebrafish (Danio rerio) as a "middle ground" model. It offers the biological complexity of a vertebrate alongside the scalability and transparency of in vitro systems, allowing for real-time observation of how tumor cells migrate, interact with the vasculature, and evade the immune system.
Methodological Pillars of Zebrafish Modeling
The review categorizes zebrafish glioma modeling into three primary strategies:
- Chemical Mutagenesis: Utilizing alkylating agents like ENU and MNNG to induce random point mutations. This approach is instrumental for large-scale discovery of novel oncogenic pathways, despite its lack of precision.
- Genetic Engineering: Advanced tools such as CRISPR/Cas9, the Gal4-UAS system, and Transgene Electroporation in Adult Zebrafish (TEAZ) allow for precise manipulation. Researchers can knock out tumor suppressors (e.g., tp53) or overexpress oncogenes (e.g., AKT) in specific brain regions.
- Xenotransplantation: Often considered the "gold standard" for translational research, this involves microinjecting fluorescently labeled human glioma cells into zebrafish embryos. The lack of an adaptive immune system in early-stage zebrafish prevents rejection, enabling the study of human cancer behavior in a live vertebrate brain.
Key Insights: Visualizing the Tumor Microenvironment
Zebrafish models provide unique advantages for studying tumor dynamics:
- The "Immune Window": The delayed development of adaptive immunity (first 28 days) allows researchers to isolate and study the innate immune response—specifically macrophages and neutrophils—without interference from T-cells and B-cells.
- Optical Transparency: The clarity of zebrafish embryos enables high-resolution 3D time-lapse imaging. This has been pivotal in observing "vessel co-option," where tumor cells utilize existing blood vessels to facilitate spread.
- Genetic Fidelity: Zebrafish share approximately 87% genetic homology with humans in key glioma-related pathways, such as the RTK/Ras/PI3K axis.
- High-Throughput Screening: The ability to house zebrafish in 96-well plates facilitates rapid, automated testing of thousands of compounds or novel delivery systems, such as neutrophil-derived exosomes.
Results and Therapeutic Validation
The efficacy of these models is demonstrated through several key findings:
- Invasion Dynamics: Xenotransplantation of U87 cells showed that tumor cells can occupy nearly 20% of the zebrafish brain within days, with mortality rates reaching 40%.
- Genetic Modeling Success: Activating the AKT pathway via specific enhancers resulted in tumor-like growths in 49% of subjects by nine months, closely mimicking human disease progression.
- Therapeutic Validation: The review highlights successful trials where PI3K inhibitors (LY294002) and radiotherapy were validated, showing significant tumor reduction with minimal systemic toxicity.
Limitations and the Path Forward
Despite their promise, zebrafish models face several "biological gaps":
- The Temperature Trap: Zebrafish thrive at 28°C, while human cells require 37°C. A compromise of 35°C is often used, but this can induce stress in the fish and alter tumor growth kinetics.
- Physiological Timing: The development of the BBB and myelination in zebrafish may not align perfectly with the window for embryonic tumor injection.
- Gene Duplication: The zebrafish genome contains many paralogs due to an ancient duplication event, which can complicate CRISPR knockout experiments through functional redundancy.
The future of the field lies in "humanized" zebrafish—strains engineered to produce human cytokines or high-temperature resistant mutants. Integrating these models with single-cell RNA sequencing (scRNA-seq) will allow for an unprecedented mapping of the complex dialogue between glioma cells and the brain microenvironment.
Summary updated